Quadrant Capital Group LLC Relay Therapeutics, Inc. Transaction History
Quadrant Capital Group LLC
- $3 Billion
- Q3 2025
A detailed history of Quadrant Capital Group LLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Quadrant Capital Group LLC holds 11,791 shares of RLAY stock, worth $78,056. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,791
Previous 11,791
-0.0%
Holding current value
$78,056
Previous $40,000
52.5%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding RLAY
# of Institutions
215Shares Held
168MCall Options Held
714KPut Options Held
14.9K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$185 Million1.1% of portfolio
-
Commodore Capital LP New York, NY17MShares$113 Million5.66% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct14.8MShares$97.8 Million0.15% of portfolio
-
Casdin Capital, LLC New York, NY11.3MShares$75.1 Million8.07% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$69.8 Million0.0% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $796M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...